ID   MM-C1
AC   CVCL_M537
DR   Wikidata; Q54906017
RX   DOI=10.1007/0-306-46877-8_4;
RX   PubMed=2072743;
RX   PubMed=10936422;
CC   Population: Japanese.
CC   Characteristics: Produces IgG lambda.
CC   Characteristics: IL6 dependent.
CC   Doubling time: 96 hours (PubMed=2072743).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 13
//
RX   DOI=10.1007/0-306-46877-8_4;
RA   Jernberg-Wiklund, Helena
RA   Nilsson, Kenneth
RT   "Multiple myeloma cell lines.";
RL   (In book chapter) Human cell culture. Vol. 3. Cancer cell lines part 3; Masters, John R.W. & Palsson, Bernhard Orn (eds.); pp.81-155; Kluwer Academic Publishers; New York; USA (2000).
//
RX   PubMed=2072743;
RA   Okuno, Yoshiaki
RA   Takahashi, Takayuki
RA   Suzuki, Akira
RA   Ichiba, Shigemoto
RA   Nakamura, Kishiko
RA   Fukumoto, Manabu
RA   Okada, Takamichi
RA   Okada, Hiromu
RA   Imura, Hiroo
RT   "Establishment and characterization of four myeloma cell lines which
RT   are responsive to interleukin-6 for their growth.";
RL   Leukemia 5:585-591(1991).
//
RX   PubMed=10936422; DOI=10.1016/S0145-2126(99)00195-2;
RA   Drexler, Hans Gunther
RA   Matsuo, Yoshinobu
RT   "Malignant hematopoietic cell lines: in vitro models for the study of
RT   multiple myeloma and plasma cell leukemia.";
RL   Leuk. Res. 24:681-703(2000).
//